Selected Grants
Serum pro-N-cadherin as an early biomarker of radiation-induced heart disease
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2025 - 2030Multi-institutional validation of a multi-modal machine learning algorithm to predict and reduce acute care during cancer therapy
ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2024 - 2028NCI National Clinical Trials Network (UG1)
Clinical TrialCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2026PROCEED
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme · 2017 - 2025GTI-4711-201 GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711
Clinical TrialPrincipal Investigator · Awarded by Galera Therapeutics, Inc. · 2021 - 2024Inhibition of CaMKK2 sensitizes rectal cancers to radiation therapy
ResearchCollaborator · Awarded by National Institutes of Health · 2021 - 2022Knowledge-based Tutoring for Knowledge-based Radiation Therapy
ResearchCo Investigator · Awarded by Varian Medical Systems, Inc. · 2020 - 2022Clinical Experience Guided Reinforcement Learning for Pancreas SBRT
ResearchCollaborating Investigator · Awarded by Varian Medical Systems, Inc. · 2019 - 2022Hybrid virtual-MRI/CBCT: A new paradigm for image guidance in liver SBRT
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2021External Relationships
- Merck
- Syntactx
- UpToDate, Inc
- Varian Medical Systems
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.